Milan Puskar
Plus aucun poste en cours
Historique de carrière de Milan Puskar
Anciens postes connus de Milan Puskar
Sociétés | Poste | Début | Fin |
---|---|---|---|
Centra Bank, Inc. (Morgantown, West Virginia)
Centra Bank, Inc. (Morgantown, West Virginia) Regional BanksFinance Centra Bank, Inc. provides banking services. It offers personal, business, and mortgage services including personal loans, money market, mortgage, online banking, title insurance, cash management, bank loans, and credit cards. The company was founded by John T. Fahey and Douglas J. Leech on October 25, 1999 and is headquartered in Morgantown, MV. | Directeur/Membre du Conseil | - | 07/10/2011 |
West Virginia University | Corporate Officer/Principal | 01/01/1979 | 07/10/2011 |
Protea Biosciences, Inc.
Protea Biosciences, Inc. Medical SpecialtiesHealth Technology Protea Biosciences, Inc. develops technology for micro fluidic protein separation and detection. The firm develops new technology for the identification, characterization, and quantization of biologically-important molecules for basic research, pharmaceutical development, and diagnostic applications. the company was founded by Steve Turner in 2001 and is headquartered in Morgantown, WV. | Directeur/Membre du Conseil | - | 07/10/2011 |
Centra Financial Holdings, Inc.
Centra Financial Holdings, Inc. Financial ConglomeratesFinance Centra Financial Holdings, Inc. operated as a bank holding company. The company was founded in October 25, 1999 and was headquartered in Morgantown, WV. | Directeur/Membre du Conseil | 05/07/2011 | 07/10/2011 |
Independent Dir/Board Member | 05/07/2011 | 07/10/2011 | |
SRKP 5, Inc.
SRKP 5, Inc. Miscellaneous Commercial ServicesCommercial Services SRKP 5, Inc. was incorporated in the State of Delaware on May 24, 2005. Since inception, the company has been engaged in organizational efforts and obtaining initial financing. The firm was formed as a vehicle to pursue a business combination through the acquisition of, or merger with, an operating business. The firm, based on proposed business activities, is a 'blank check' company. It was organized as a vehicle to investigate and, if such investigation warrants, acquire a target company or business seeking the perceived advantages of being a publicly held corporation. The company will not restrict its potential candidate target companies to any specific business, industry or geographical location and, thus, may acquire any type of business. | Directeur/Membre du Conseil | 07/09/2011 | 07/10/2011 |
PROTEA BIOSCIENCES GROUP, INC | Directeur/Membre du Conseil | 01/09/2006 | 07/10/2011 |
Mylan, Inc.
Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Directeur/Membre du Conseil | 01/10/2009 | 01/10/2009 |
Fondateur | 01/01/1961 | 01/10/2009 | |
Mylan Laboratories, Inc.
Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Mylan Laboratories, Inc. is engaged in developing, licensing, manufacturing, marketing and distributing generic and brand pharmaceutical products. The company manufactures and markets over 140 generic products in approximately 360 product strengths covering over 40 therapeutic categories. The company manufactures products for conditions ranging from angina to arthritis, depression to diabetes, pain to Parkinson's disease and schizophrenia to sleep disorders. The company operates through its three subsidiaries: a) Mylan Pharmaceuticals (Morgantown, West Virginia) is primarily focused on solid oral dose generic pharmaceutical products. b) Mylan Technologies (St. Albans, Vermont) is the pioneer in generic transdermal drug delivery technology and is the producer of generic transdermal patches for the U.S. market. c) UDL Laboratories (Rockford, Illinois) is the number one supplier of unit dose pharmaceuticals to hospitals and other institutions across the United States. The company was incorporated in 1970 and is headquartered in Canonsburg, PA. | Président | 01/01/1976 | 02/10/2007 |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01/01/1972 | 01/01/1975 |
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░░░ ░░░ ░░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░░░░ ░░ ░░░ ░░░░ ░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░ ░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Formation de Milan Puskar
Youngstown State University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 14 |
Irlande | 2 |
Opérationnelle
Director/Board Member | 7 |
Corporate Officer/Principal | 3 |
Founder | 2 |
Sectorielle
Health Technology | 7 |
Consumer Services | 4 |
Commercial Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 11 |
---|---|
Mylan Laboratories, Inc.
Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Mylan Laboratories, Inc. is engaged in developing, licensing, manufacturing, marketing and distributing generic and brand pharmaceutical products. The company manufactures and markets over 140 generic products in approximately 360 product strengths covering over 40 therapeutic categories. The company manufactures products for conditions ranging from angina to arthritis, depression to diabetes, pain to Parkinson's disease and schizophrenia to sleep disorders. The company operates through its three subsidiaries: a) Mylan Pharmaceuticals (Morgantown, West Virginia) is primarily focused on solid oral dose generic pharmaceutical products. b) Mylan Technologies (St. Albans, Vermont) is the pioneer in generic transdermal drug delivery technology and is the producer of generic transdermal patches for the U.S. market. c) UDL Laboratories (Rockford, Illinois) is the number one supplier of unit dose pharmaceuticals to hospitals and other institutions across the United States. The company was incorporated in 1970 and is headquartered in Canonsburg, PA. | Health Technology |
Centra Bank, Inc. (Morgantown, West Virginia)
Centra Bank, Inc. (Morgantown, West Virginia) Regional BanksFinance Centra Bank, Inc. provides banking services. It offers personal, business, and mortgage services including personal loans, money market, mortgage, online banking, title insurance, cash management, bank loans, and credit cards. The company was founded by John T. Fahey and Douglas J. Leech on October 25, 1999 and is headquartered in Morgantown, MV. | Finance |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Health Technology |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland. | Health Technology |
Mylan Pharmaceuticals, Inc.
Mylan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mylan Pharmaceuticals, Inc. develops and manufactures generic prescription products. Its product includes tablets, Fosamax, Sectral, Xanax, capsules, liquids, and transdermal patches. The company was founded in 1961 and is headquartered in Morgantown, WV. | Health Technology |
Protea Biosciences, Inc.
Protea Biosciences, Inc. Medical SpecialtiesHealth Technology Protea Biosciences, Inc. develops technology for micro fluidic protein separation and detection. The firm develops new technology for the identification, characterization, and quantization of biologically-important molecules for basic research, pharmaceutical development, and diagnostic applications. the company was founded by Steve Turner in 2001 and is headquartered in Morgantown, WV. | Health Technology |
Centra Financial Holdings, Inc.
Centra Financial Holdings, Inc. Financial ConglomeratesFinance Centra Financial Holdings, Inc. operated as a bank holding company. The company was founded in October 25, 1999 and was headquartered in Morgantown, WV. | Finance |
Mylan, Inc.
Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Health Technology |
Association for Accessible Medicines
Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Commercial Services |
SRKP 5, Inc.
SRKP 5, Inc. Miscellaneous Commercial ServicesCommercial Services SRKP 5, Inc. was incorporated in the State of Delaware on May 24, 2005. Since inception, the company has been engaged in organizational efforts and obtaining initial financing. The firm was formed as a vehicle to pursue a business combination through the acquisition of, or merger with, an operating business. The firm, based on proposed business activities, is a 'blank check' company. It was organized as a vehicle to investigate and, if such investigation warrants, acquire a target company or business seeking the perceived advantages of being a publicly held corporation. The company will not restrict its potential candidate target companies to any specific business, industry or geographical location and, thus, may acquire any type of business. | Commercial Services |
Protea Biosciences Group, Inc.
Protea Biosciences Group, Inc. Miscellaneous Commercial ServicesCommercial Services Protea Biosciences Group, Inc. engaged in the provision of molecular information services. It offers direct analysis, mapping, and display of biologically active molecules in living cells and tissue samples through its platform technology. The company was founded by Stephen C. Turner in July 2001 and was headquartered in Morgantown, WV. | Commercial Services |
- Bourse
- Insiders
- Milan Puskar
- Expérience